Patents by Inventor Stephen Harper
Stephen Harper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12195534Abstract: The present invention relates to binding molecules that comprise T cell receptor (TCR) variable domains and which can bind to a PIWIL1 peptide-HLA complex. The invention also relates to the use of such molecules for the treatment of malignant diseases.Type: GrantFiled: January 5, 2024Date of Patent: January 14, 2025Assignee: IMMUNOCORE LIMITEDInventors: Nicole Mai, Arnaud Techine, Jakub Jaworski, Kate Atkin, Nathaniel Liddy, Vijaykumar Karuppiah, Ana Pereira Ribeiro, Ana Penas, Andrew Creese, Emma Grant, Stephen Harper, Chandramouli Chillakuri, Eduardo Mateos-Diaz, Tamara Aleksic, Pedro Cuadrado Rodenas
-
Publication number: 20240368243Abstract: The present invention relates to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide SLLQHLIGL (SEQ ID NO: 1) derived from the germline cancer antigen PRAME. Said TCRs may comprise non-natural mutations within the alpha and/or beta variable domains relative to a native PRAME TCR. The TCRs of the invention are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant disease.Type: ApplicationFiled: May 15, 2024Publication date: November 7, 2024Inventors: Philip William ADDIS, Nicole Joy BEDKE, Lucie BOUARD, Stephen HARPER, Nathaniel LIDDY, Tara Mahon, Ronan Padraic O'Dwyer
-
Publication number: 20240254228Abstract: The present invention relates to binding molecules that comprise T cell receptor (TCR) variable domains and which can bind to a PIWIL1 peptide-HLA complex. The invention also relates to the use of such molecules for the treatment of malignant diseases.Type: ApplicationFiled: January 5, 2024Publication date: August 1, 2024Inventors: Nicole MAI, Arnaud TECHINE, Jakub JAWORSKI, Kate ATKIN, Nathaniel LIDDY, Vijaykumar KARUPPIAH, Ana PEREIRA RIBEIRO, Ana PENAS, Andrew CREESE, Emma GRANT, Stephen HARPER, Chandramouli CHILLAKURI, Eduardo MATEOS-DIAZ, Tamara ALEKSIC, Pedro CUADRADO RODENAS
-
Patent number: 12018062Abstract: The present invention relates to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide SLLQHLIGL (SEQ ID NO: 1) derived from the germline cancer antigen PRAME. Said TCRs may comprise non-natural mutations within the alpha and/or beta variable domains relative to a native PRAME TCR. The TCRs of the invention are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant disease.Type: GrantFiled: May 26, 2023Date of Patent: June 25, 2024Assignee: Immunocore LimitedInventors: Philip William Addis, Nicole Joy Bedke, Lucie Bouard, Stephen Harper, Nathaniel Liddy, Tara Mahon, Ronan Pádraic O'Dwyer
-
Publication number: 20230416335Abstract: The present invention relates to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide SLLQHLIGL (SEQ ID NO: 1) derived from the germline cancer antigen PRAME. Said TCRs may comprise non-natural mutations within the alpha and/or beta variable domains relative to a native PRAME TCR. The TCRs of the invention are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant disease.Type: ApplicationFiled: May 26, 2023Publication date: December 28, 2023Inventors: Philip William ADDIS, Nicole Joy BEDKE, Lucie BOUARD, Stephen HARPER, Nathaniel LIDDY, Tara MAHON, Ronan Pádraic O'DWYER
-
Patent number: 11718657Abstract: The present invention relates to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide SLLQHLIGL (SEQ ID NO: 1) derived from the germline cancer antigen PRAME. Said TCRs may comprise non-natural mutations within the alpha and/or beta variable domains relative to a native PRAME TCR. The TCRs of the invention are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant disease.Type: GrantFiled: June 19, 2018Date of Patent: August 8, 2023Assignee: Immunocore LimitedInventors: Philip William Addis, Nicole Joy Bedke, Lucie Bouard, Stephen Harper, Nathaniel Liddy, Tara Mahon, Ronan Pádraic O'Dwyer
-
Patent number: 11427624Abstract: The present invention relates to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide SLLQHLIGL (SEQ ID NO: 1) derived from the germline cancer antigen PRAME. Said TCRs may comprise non-natural mutations within the alpha and/or beta variable domains relative to a native PRAME TCR. The TCRs of the invention are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant disease.Type: GrantFiled: December 15, 2021Date of Patent: August 30, 2022Assignee: Immunocore LimitedInventors: Philip William Addis, Nicole Joy Bedke, Lucie Bouard, Stephen Harper, Nathaniel Liddy, Tara Mahon, Ronan Pádraic O'Dwyer
-
Patent number: 11363702Abstract: A light system configured for reserving and/or dynamically moving/arranging spaces for participants in a class may include a plurality of cells disposed on a surface, each cell having one or more lights disposed therein. Each light is in communication with a controller configured to control at least one of a color, a pattern, and a brightness of each light. The light system may be configured to allow a participant of the class to reserve a space prior to the class and have the space emit light indicating the space is reserved proximate a start time of the class.Type: GrantFiled: April 20, 2021Date of Patent: June 14, 2022Assignee: CHROMO LIGHTING, LLCInventors: Robert Kittleman, Sam Goljahi, Stephen Harper
-
Publication number: 20220177541Abstract: The present invention relates to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide SLLQHLIGL (SEQ ID NO: 1) derived from the germline cancer antigen PRAME. Said TCRs may comprise non-natural mutations within the alpha and/or beta variable domains relative to a native PRAME TCR. The TCRs of the invention are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant disease.Type: ApplicationFiled: December 15, 2021Publication date: June 9, 2022Inventors: Philip William ADDIS, Nicole Joy BEDKE, Lucie BOUARD, Stephen HARPER, Nathaniel LIDDY, Tara MAHON, Ronan Pádraic O'DWYER
-
Publication number: 20220119527Abstract: A specific binding molecule which binds to CD3 and comprises a polypeptide having an immunoglobulin VL domain and an immunoglobulin VH domain in which the VL domain comprises Complementarity Determining Regions (CDRs) VLCDR1, VLCDR2 and VLCDR3, and in which the VH domain comprises Complementarity Determining Regions (CDRs) VHCDR1, VHCDR2, VHCDR3, each having a respective amino acid sequence as follows in which (SEQ?ID?NO:?1) VLCDR1?is?QDIRNY VLCDR2?is?YTS (SEQ?ID?NO:?2) VLCDR3?is?QQGNTLPWT (SEQ?ID?NO:?3) VHCDR1?is?GYSFTGYA (SEQ?ID?NO:?4) VHCDR2?is?INPYKGVS (SEQ?ID?NO:?5) VHCDR3?is?ARSGYYGDSDWYFDV or an amino acid sequence at least 70% identical thereto.Type: ApplicationFiled: January 30, 2020Publication date: April 21, 2022Inventors: Martina CANESTRARO, Nele DIECKMANN, Stephen HARPER, Peter Benedict KIRK, Rachel MULVANEY, Ronan O'DWYER, Ian Butler ROBERTSON
-
Publication number: 20210355188Abstract: The present invention relates to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide SLLQHLIGL (SEQ ID NO: 1) derived from the germline cancer antigen PRAME. Said TCRs may comprise non-natural mutations within the alpha and/or beta variable domains relative to a native PRAME TCR. The TCRs of the invention are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant disease.Type: ApplicationFiled: June 19, 2018Publication date: November 18, 2021Inventors: Philip William ADDIS, Nicole Joy BEDKE, Lucie BOUARD, Stephen HARPER, Nathaniel LIDDY, Tara MAHON, Ronan Pádraic O'DWYER
-
Publication number: 20210243871Abstract: A light system configured for reserving and/or dynamically moving/arranging spaces for participants in a class may include a plurality of cells disposed on a surface, each cell having one or more lights disposed therein. Each light is in communication with a controller configured to control at least one of a color, a pattern, and a brightness of each light. The light system may be configured to allow a participant of the class to reserve a space prior to the class and have the space emit light indicating the space is reserved proximate a start time of the class.Type: ApplicationFiled: April 20, 2021Publication date: August 5, 2021Inventors: Robert Kittleman, Sam Goljahi, Stephen Harper
-
Patent number: 11013092Abstract: A light system configured for reserving and/or dynamically moving/arranging spaces for participants in a class may include a plurality of cells disposed on a surface, each cell having one or more lights disposed therein. Each light is in communication with a controller configured to control at least one of a color, a pattern, and a brightness of each light. The light system may be configured to allow a participant of the class to reserve a space prior to the class and have the space emit light indicating the space is reserved proximate a start time of the class.Type: GrantFiled: February 28, 2020Date of Patent: May 18, 2021Assignee: CHROMO LIGHTING, LLCInventors: Robert Kittleman, Sam Goljahi, Stephen Harper
-
Patent number: 10806175Abstract: Systems, methods, and devices for heat management of heating implements for a water pipe.Type: GrantFiled: May 8, 2018Date of Patent: October 20, 2020Assignee: Kaloud, Inc.Inventors: Reza Bavar, Tylor Garland, Michael Latham, Stephen Bradford, Richard Siemer, Mark Hummel, Wilson Reniers, Stephen Harper, Andrew Castro
-
Publication number: 20200281063Abstract: A light system configured for reserving and/or dynamically moving/arranging spaces for participants in a class may include a plurality of cells disposed on a surface, each cell having one or more lights disposed therein. Each light is in communication with a controller configured to control at least one of a color, a pattern, and a brightness of each light. The light system may be configured to allow a participant of the class to reserve a space prior to the class and have the space emit light indicating the space is reserved proximate a start time of the class.Type: ApplicationFiled: February 28, 2020Publication date: September 3, 2020Inventors: Robert Kittleman, Sam Goljahi, Stephen Harper
-
Publication number: 20180317545Abstract: Systems, methods, and devices for heat management of heating implements for a water pipe.Type: ApplicationFiled: May 8, 2018Publication date: November 8, 2018Inventors: Reza Bavar, Tylor Garland, Michael Latham, Stephen Bradford, Richard Siemer, Mark Hummel, Wilson Reniers, Stephen Harper, Andrew Castro
-
Patent number: 10092034Abstract: A multi-chambered water pipe comprising an inner chamber and exterior chamber.Type: GrantFiled: March 31, 2017Date of Patent: October 9, 2018Assignee: KALOUD, INC.Inventors: Reza Bavar, Tylor Garland, Michael Latham, Stephen Bradford, Richard Siemer, Mark Hummel, Wilson Reniers, Stephen Harper, Andrew Castro
-
Publication number: 20180213840Abstract: A multi-chambered water pipe comprising an inner chamber and exterior chamber.Type: ApplicationFiled: February 1, 2017Publication date: August 2, 2018Inventors: Reza Bavar, Tylor Garland, Michael Latham, Stephen Bradford, Richard Seimer, Mark Hummel, Wilson Reniers, Stephen Harper, Andrew Castro
-
Publication number: 20180213841Abstract: A multi-chambered water pipe comprising an inner chamber and exterior chamber.Type: ApplicationFiled: March 31, 2017Publication date: August 2, 2018Inventors: Reza Bavar, Tylor Garland, Michael Latham, Stephen Bradford, Richard Siemer, Mark Hummel, Wilson Reniers, Stephen Harper, Andrew Castro
-
Patent number: 10034491Abstract: A multi-chambered water pipe comprising an inner chamber and exterior chamber.Type: GrantFiled: February 1, 2017Date of Patent: July 31, 2018Assignee: KALOUD, INC.Inventors: Reza Bavar, Tylor Garland, Michael Latham, Stephen Bradford, Richard Seimer, Mark Hummel, Wilson Reniers, Stephen Harper, Andrew Castro